Implementation of evidence-based therapy in patients with systolic heart failure from 1998-2000

Clinical Research in Cardiology

Volumn 95, Issue 3, 2006, Pages 154-161

  Reibis, R ^a   Dovifat, C ^a   Dissmann, R ^b   Ehrlich, B ^a   Schulz, S ^a   Stolze, K ^a   Wegscheider, K ^c   Voller H ^a  

^a Klinik am See   (Germany)

^b Zentralkrankenhaus Reinkenheide   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Guideline based therapy; Heart failure; Mortality

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCOSIDE; HYDRALAZINE PLUS ISOSORBIDE DINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; NITRATE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG INDICATION; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART REHABILITATION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MCNEMAR TEST; MORTALITY; NONPARAMETRIC TEST; OUTPATIENT; PRACTICE GUIDELINE; PRESCRIPTION; REGISTER; SYSTOLE; VALVULAR HEART DISEASE;

AGED; CARDIOTONIC AGENTS; EVIDENCE-BASED MEDICINE; FEMALE; GERMANY; GUIDELINE ADHERENCE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; INCIDENCE; INPATIENTS; MALE; OUTPATIENTS; PATIENT COMPLIANCE; PRACTICE GUIDELINES; PRESCRIPTIONS, DRUG; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 33644691182     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-006-0348-0     Document Type: Article

References (32)

1. American Heart Association (2002) Heart and Stroke Statistical Update. Dallas, Texas. American Heart Association
2. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) (1987) The CONSENSUS Trial Study Group. N Engl J Med 316:1429-1435
3. Hjalmarson A, Goldstein S, Fagerberg B et al (2000) Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA 283:1295-1302
4. Bohm M, Maack C, Wehrlen-Grandjean M, Erdmann E (2003) Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)). Z Kardiol 92:668-676
5. Pitt B, Zannad F, Remme WJ et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341:709-717
6. Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ et al (2003) Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 362:759-766
7. Hunt SA, Baker DW, Chin MH et al (2001) ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 38:2101-2113
8. Remme WJ, Swedberg K (2002) European society of cardiology. Comprehensive guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur J Heart Fail 4:11-22
9. Butler J, Arbogast PG, Daugherty J et al (2004) Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge. J Am Coll Cardiol 43:2036-2043
10. Ferreira A, Bettencourt P, Cortez M et al (1997) Angiotensin-converting enzyme inhibitors in heart failure: physicians' prescribing behavior. J Card Fail 3:295-302
11. Muntwyler J, Cohen-Solal A, Freemantle N et al (2004) Relation of sex, age and concomitant diseases to drug prescription for heart failure in primary care in Europe. Eur J Heart Fail 6:663-668
12. Faggiano P, Opasich C, Tavazzi L et al (2003) Prescription patterns of diuretics in chronic heart failure: a contemporary background as a clue to their role in treatment. J Card Fail 9:210-218
13. Hoppe UC, Erdmann E (1998) Leitlinien zur Therapie der chronischen Herzinsuffizienz. Im Auftrag der Deutschen Gesellschaft für Kardiologie. Z Kardio 87:645-658
14. th edition. Philadelphia, Lea & Febiger, pp 138-140
15. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure (1993) The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Lancet 342:821-828
16. Hoppe UC, Böhm M, Dietz R, Hanrath P, Kroemer HK et al (2005) Leitlinien zur Therapie der chronischen Herzinsuffizienz. Z Kardiol 94:488-509
17. Ceia F, Fonseca C, Mota T, Morais H, Matias F, Costa C, Oliveira AG (2004) Aetiology, comorbidity and drug therapy of chronic heart failure in the real world: the EPICA substudy. Eur J Heart Fail 6:801-806
18. McKee SP, Leslie SJ, LeMaitre JP, Webb DJ, Denvir MA (2003) Management of chronic heart failure due to systolic left ventricular dysfunction by cardiologist and non-cardiologist physicians. Eur J Heart Fail 5:549-555
19. Komajda M, Lapuerta P, Hermans N, Gonzalez-Juanatey JR, van Veldhuisen DJ et al (2005) Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J 26:1653-1659
20. Poole-Wilson PA, Swedberg K, Cleland JG et al (2003) Carvedilol or metoprolol european trial investigators. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 362:7-13
21. Gupta R, Tang WH, Young JB (2004) Patterns of beta-blockers utilization in patients with chronic heart failure: experience from a specialized outpatient heart failure clinic. Am Heart J 147:79-83
22. Drechsler K, Dietz R, Klein H, Wollert KC, Storp D, Molling J, Zeymer U, Niebauer J (2005) Euro heart failure survey Medical treatment not in line with current guidelines. Z Kardiol 94:510-515
23. Baxter AJ, Spensley A, Hildreth A et al (2002) Beta blockers in older persons with heart failure: tolerability and impact on quality of life. Heart 88:611-614
24. Gheorghiade M, Adams KF Jr, Colucci WS (2004) Digoxin in the management of cardiovascular disorders. Circulation 109:2959-2964
25. Komajda M, Follath F, Swedberg K et al (2003) Study group on diagnosis of the working group on heart failure of the european society of cardiology. The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 24:464-474
26. Feinglass J, Martin GJ, Lin E et al (2003) Is heart failure survival improving? Evidence from 2323 elderly patients hospitalized between 1989-2000. Am Heart J 146:111-114
27. Majumdar SR, McAlister FA, Cree M, Chang WC, Packer M, Armstrong PW (2004) ATLAS Study Group. Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. Clin Ther 26:694-703
28. Stewart S, MacIntyre K, Hole DJ et al (2001) More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 3:315-322
29. Ho KK, Anderson KM, Kannel WB et al (1993) Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 88:107-115
30. Flesch M, Komajda M, Lapuerta P, Hermans N, Le Pen C, Gonzales-Juanatey JR, Van Veldhuisen DJ, Tavazzi L, Poole-Wilson P, Erdmann E (2005) Adherence to guidelines in CHF therapy in Germany. Dtsch Med Wochenschr 130:2191-2197
31. Miche E, Herrmann G, Wirtz U, Laki H, Barth M et al (2003) Effects of education, self-care instruction and physical exercise on patients with chronic heart failure. Z Kardiol 92:985-993
32. Cleland JG, Cohen-Solal A, Aguilar JC, Dietz R, Eastaugh J et al (2002) Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 360:1631-1639